DendroPharm specialises in the development, manufacture and analysis of innovative, nanotechnology-based medicines. We work in compliance with GMP guidelines.

Tackling the opioid crisis. Development of safe and non-addictive opioids.

About us

DendroPharm is a biotech company based in Berlin, specializing in innovative dendritic nanocarriers for targeted drug delivery.

Our mission is to improve patient care by enhancing drug effectiveness and reducing side effects.

Built on years of academic research, we combine scientific expertise with GMP-compliant production to develop safe and efficient therapies.

EU-Funded Research Project​

This project, funded by the European Union under the Pro FIT program (January 1, 2023 – September 30, 2025), aims to develop innovative mucoadhesive carriers to improve the bioavailability and tolerability of cannabis extracts. It also includes the development of a device for measuring mucoadhesivity and a standardized method for assessing nanocarrier loading.

Why choose us

End-to-End

From discovery to GMP production, we manage every step.

Validated GMP Production

Manufacturing fully compliant with GMP standards.

Advanced Facilities

800 m² of clean rooms, labs, storage, and production in Berlin.

Integrated Site

All resources under one roof for optimal efficiency.

Scroll to Top